Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

GeneDx Holdings (WGS) Shares Outstanding (Diluted Average) (2020 - 2025)

Historic Shares Outstanding (Diluted Average) for GeneDx Holdings (WGS) over the last 6 years, with Q3 2025 value amounting to $28.8 million.

  • GeneDx Holdings' Shares Outstanding (Diluted Average) rose 628.04% to $28.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.8 million, marking a year-over-year increase of 628.04%. This contributed to the annual value of $26.9 million for FY2024, which is 1060.89% up from last year.
  • As of Q3 2025, GeneDx Holdings' Shares Outstanding (Diluted Average) stood at $28.8 million, which was up 628.04% from $29.8 million recorded in Q2 2025.
  • Over the past 5 years, GeneDx Holdings' Shares Outstanding (Diluted Average) peaked at $210.3 million during Q3 2021, and registered a low of $549778.0 during Q1 2021.
  • Over the past 5 years, GeneDx Holdings' median Shares Outstanding (Diluted Average) value was $25.8 million (recorded in 2023), while the average stood at $34.1 million.
  • In the last 5 years, GeneDx Holdings' Shares Outstanding (Diluted Average) surged by 210626209.32% in 2021 and then tumbled by 9451.42% in 2022.
  • Quarter analysis of 5 years shows GeneDx Holdings' Shares Outstanding (Diluted Average) stood at $108.1 million in 2021, then tumbled by 90.53% to $10.2 million in 2022, then skyrocketed by 137.49% to $24.3 million in 2023, then increased by 10.61% to $26.9 million in 2024, then rose by 7.09% to $28.8 million in 2025.
  • Its Shares Outstanding (Diluted Average) stands at $28.8 million for Q3 2025, versus $29.8 million for Q2 2025 and $28.1 million for Q1 2025.